BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21115117)

  • 1. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
    Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
    Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited neuropathies: new genes don't fit old models.
    Scherer SS
    Neuron; 2006 Sep; 51(6):672-4. PubMed ID: 16982409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.
    Wallen RC; Antonellis A
    Curr Opin Genet Dev; 2013 Jun; 23(3):302-9. PubMed ID: 23465884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.
    Storkebaum E
    Bioessays; 2016 Sep; 38(9):818-29. PubMed ID: 27352040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tRNA synthetases in neurological and neuromuscular disorders.
    Boczonadi V; Jennings MJ; Horvath R
    FEBS Lett; 2018 Mar; 592(5):703-717. PubMed ID: 29288497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
    Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
    Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aminoacyl-tRNA synthetases in genetic diseases.
    Antonellis A; Green ED
    Annu Rev Genomics Hum Genet; 2008; 9():87-107. PubMed ID: 18767960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
    Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
    Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.
    Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R
    J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).
    Seo AJ; Shin YH; Lee SJ; Kim D; Park BS; Kim S; Choi KH; Jeong NY; Park C; Jang JY; Huh Y; Jung J
    J Mol Histol; 2014 Apr; 45(2):121-8. PubMed ID: 23990368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
    Wei N; Zhang Q; Yang XL
    J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect.
    Nangle LA; Zhang W; Xie W; Yang XL; Schimmel P
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11239-44. PubMed ID: 17595294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy.
    Rhymes ER; Simkin RL; Qu J; Villarroel-Campos D; Surana S; Tong Y; Shapiro R; Burgess RW; Yang XL; Schiavo G; Sleigh JN
    Neurobiol Dis; 2024 Jun; 195():106501. PubMed ID: 38583640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.